Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ZYME	Zymeworks Inc. Manufacturing · Year ended 2025-12-31 · USD	$105.97M	-$81.13M	-76.6%	-30.2%	38.9%	-$1.08
ZVSA	ZyVersa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$24.95M	n/a	n/a	n/a	-$4.18
ZVRA	Zevra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$106.47M	$83.23M	78.2%	53.8%	350.9%	$1.35
ZTS	Zoetis Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.47B	$2.67B	28.2%	80.2%	2.3%	$6.02
ZOMDF	Zomedica Corp. Manufacturing · Year ended 2025-12-31 · USD	$32.03M	-$81.86M	-255.6%	-70.9%	17.4%	-$0.08
ZNTL	Zentalis Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$137.06M	n/a	-63.4%	-100.0%	-$1.91
ZLAB	Zai Lab Ltd Manufacturing · Year ended 2025-12-31 · USD	$457.18M	-$175.54M	-38.4%	-24.5%	15.0%	-$0.16
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
YARW	Yarrow Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$570.0K	-$26.48M	n/m	-95.4%	13.8%	-$0.62
XNCR	Xencor Inc Manufacturing · Year ended 2025-12-31 · USD	$125.58M	-$91.92M	-73.2%	-14.5%	13.7%	-$1.24
XLO	Xilio Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$43.77M	-$35.04M	-80.1%	-99.3%	589.9%	-$4.19
XERS	Xeris Biopharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$291.85M	$554.0K	0.2%	4.0%	43.7%	$0.00
XENE	Xenon Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.50M	-$345.91M	n/m	-59.5%	n/a	-$4.36
XCUR	Exicure, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$4.95M	n/a	-126.0%	-100.0%	-$0.79
XBIT	XBiotech Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.54M	n/a	-32.4%	n/a	-$1.49
XBIO	Xenetic Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.98M	-$2.68M	-90.1%	-36.2%	19.0%	-$1.58
WVE	Wave Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$42.73M	-$204.38M	-478.3%	-39.4%	-60.5%	-$1.21
WHWK	Whitehawk Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.14M	-$20.60M	-288.3%	-15.1%	-72.5%	-$0.33
VTVT	vTv Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.97M	n/a	-41.9%	-100.0%	n/a
VTRS	Viatris Inc Manufacturing · Year ended 2025-12-31 · USD	$14.30B	-$3.51B	-24.6%	-23.9%	-3.0%	-$3.00
VTGN	Vistagen Therapeutics, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.27M	-$69.69M	n/m	-196.2%	161.1%	-$1.83
VSTM	Verastem, Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$209.47M	-677.6%	-366.2%	209.1%	-$3.02
VRTX	Vertex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$12.00B	$3.95B	32.9%	21.2%	8.9%	$15.32
VREOF	Vireo Growth Inc. Manufacturing · Year ended 2025-12-31 · USD	$268.77M	-$68.11M	-25.3%	-22.2%	170.4%	-$0.09
VRDN	Viridian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.85M	-$342.60M	-483.6%	-47.4%	n/m	n/a

Rows per page: 2550 100